Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,606 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Electrical stimulation with polypyrrole-coated polycaprolactone/silk fibroin scaffold promotes sacral nerve regeneration by modulating macrophage polarisation.
Cheng H, Bai J, Zhou X, Chen N, Jiang Q, Ren Z, Li X, Su T, Liang L, Jiang W, Wang Y, Peng J, Shang A. Cheng H, et al. Among authors: ren z. Biomater Transl. 2024 Jun 28;5(2):157-174. doi: 10.12336/biomatertransl.2024.02.006. eCollection 2024. Biomater Transl. 2024. PMID: 39351163 Free PMC article.
Dual-bionic regenerative microenvironment for peripheral nerve repair.
Guan Y, Ren Z, Yang B, Xu W, Wu W, Li X, Zhang T, Li D, Chen S, Bai J, Song X, Jia Z, Xiong X, He S, Li C, Meng F, Wu T, Zhang J, Liu X, Meng H, Peng J, Wang Y. Guan Y, et al. Among authors: ren z. Bioact Mater. 2023 Mar 16;26:370-386. doi: 10.1016/j.bioactmat.2023.02.002. eCollection 2023 Aug. Bioact Mater. 2023. PMID: 36942011 Free PMC article.
Cell-Derived Extracellular Matrix Materials for Tissue Engineering.
Guan Y, Yang B, Xu W, Li D, Wang S, Ren Z, Zhang J, Zhang T, Liu X, Li J, Li C, Meng F, Han F, Wu T, Wang Y, Peng J. Guan Y, et al. Among authors: ren z. Tissue Eng Part B Rev. 2022 Oct;28(5):1007-1021. doi: 10.1089/ten.TEB.2021.0147. Epub 2022 Mar 1. Tissue Eng Part B Rev. 2022. PMID: 34641714 Review.
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study.
Sangro B, Kudo M, Erinjeri JP, Qin S, Ren Z, Chan SL, Arai Y, Heo J, Mai A, Escobar J, Lopez Chuken YA, Yoon JH, Tak WY, Breder VV, Suttichaimongkol T, Bouattour M, Lin SM, Peron JM, Nguyen QT, Yan L, Chiu CF, Santos FA, Veluvolu A, Thungappa SC, Matos M, Żotkiewicz M, Udoye SI, Kurland JF, Cohen GJ, Lencioni R; EMERALD-1 Investigators. Sangro B, et al. Among authors: ren z. Lancet. 2025 Jan 8:S0140-6736(24)02551-0. doi: 10.1016/S0140-6736(24)02551-0. Online ahead of print. Lancet. 2025. PMID: 39798579
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study.
Kudo M, Ren Z, Guo Y, Han G, Lin H, Zheng J, Ogasawara S, Kim JH, Zhao H, Li C, Madoff DC, Ghobrial RM, Kawaoka T, Gerolami R, Ikeda M, Kumada H, El-Khoueiry AB, Vogel A, Peng X, Mody K, Dutcus C, Dubrovsky L, Siegel AB, Finn RS, Llovet JM; LEAP-012 investigators. Kudo M, et al. Among authors: ren z. Lancet. 2025 Jan 8:S0140-6736(24)02575-3. doi: 10.1016/S0140-6736(24)02575-3. Online ahead of print. Lancet. 2025. PMID: 39798578
Preliminary exploration of the association of CXCR6+T lymphocytes in T2D.
Zhong X, Fu B, Wang H, Zhang M, Jia S, Ren Z, Zhang Y, Wang W, Li T, Zhao J, Shi H, Chang Q, Ge F, Gong Y, Liu W, Chen S, Liao L, Zhuang Y, Tang J, Chu Y, Qiu F, Xu S, Li T. Zhong X, et al. Among authors: ren z. Int Immunopharmacol. 2025 Jan 10;147:113962. doi: 10.1016/j.intimp.2024.113962. Online ahead of print. Int Immunopharmacol. 2025. PMID: 39798468
7,606 results